242 related articles for article (PubMed ID: 28542137)
1. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
[TBL] [Abstract][Full Text] [Related]
2. DT-13, a saponin monomer 13 of the Dwarf lilyturf tuber, synergized with vinorelbine to induce mitotic arrest via activation of ERK signaling pathway in NCI-H1299 cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Biomed Pharmacother; 2017 May; 89():1277-1285. PubMed ID: 28320095
[TBL] [Abstract][Full Text] [Related]
3. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
[TBL] [Abstract][Full Text] [Related]
5. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
6. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.
Chang YC; Tseng YL; Leu WJ; Du CM; Jiang YH; Hsu LC; Hsu JL; Hou DR; Guh JH
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764382
[TBL] [Abstract][Full Text] [Related]
8. Effects of navelbine and docetaxel on gene expression in lung cancer cell strains.
Cai L; Dong HY; Sui GJ
Acta Pharmacol Sin; 2005 Aug; 26(8):1017-24. PubMed ID: 16038637
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1.
Yuan Y; Haiying G; Zhuo L; Ying L; Xin H
Biomed Pharmacother; 2018 Sep; 105():707-713. PubMed ID: 29906749
[TBL] [Abstract][Full Text] [Related]
10. Trichosanthes kirilowii fruits inhibit non-small cell lung cancer cell growth through mitotic cell-cycle arrest.
Ni L; Zhu X; Gong C; Luo Y; Wang L; Zhou W; Zhu S; Li Y
Am J Chin Med; 2015; 43(2):349-64. PubMed ID: 25779643
[TBL] [Abstract][Full Text] [Related]
11. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
[TBL] [Abstract][Full Text] [Related]
12. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of animal model of a human lung adenocarcinoma drug-resistant
cell line Anip973/NVB and investigation on mechanism of drug resistance].
Wang M; Hong X; Sun Q; Li R; Yang Z; Chen G
Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):146-51. PubMed ID: 22429577
[TBL] [Abstract][Full Text] [Related]
14. FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways.
Wu SQ; Huang SH; Lin QW; Tang YX; Huang L; Xu YG; Wang SP
Pharmacol Res; 2022 Jan; 175():106040. PubMed ID: 34954029
[TBL] [Abstract][Full Text] [Related]
15. Role of 3' repressor sequences of p53 in anti-cancer drug sensitivity of human lung tumor cells.
Wang H; Li W; Lai B; Yang X; Zhang C; Tao H; Zhu Y; Li J
Gene; 2016 Dec; 594(2):190-196. PubMed ID: 27591972
[TBL] [Abstract][Full Text] [Related]
16. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
[TBL] [Abstract][Full Text] [Related]
17. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
18. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
Zhao L; Liu L; Dong Z; Xiong J
Oncol Rep; 2017 Dec; 38(6):3522-3530. PubMed ID: 29130108
[TBL] [Abstract][Full Text] [Related]
19. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
Jiang H; Zhao PJ; Su D; Feng J; Ma SL
Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC.
Nagel R; Stigter-van Walsum M; Buijze M; van den Berg J; van der Meulen IH; Hodzic J; Piersma SR; Pham TV; Jiménez CR; van Beusechem VW; Brakenhoff RH
Mol Cancer Ther; 2015 Jun; 14(6):1434-44. PubMed ID: 25808837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]